Role of complement in in vitro and in vivo lung inflammatory reactions

Journal of Leukocyte Biology

Volumn 64, Issue 1, 1998, Pages 40-48

  Czermak, Boris J ^a,b   Lentsch, Alex B ^b   Bless, Nicolas M ^a   Schmal, Hagen ^a   Friedl, Hans Peter ^a   Ward, Peter A ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adhesion molecules; C5a; Chemokines; CVF; Endothelial cells; MAC; Rats

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; COMPLEMENT; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PADGEM PROTEIN; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

COMPLEMENT ACTIVATION; CONFERENCE PAPER; ENDOTHELIUM CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG LAVAGE; NEUTROPHIL CHEMOTAXIS; PNEUMONIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 0031745733     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.64.1.40     Document Type: Conference Paper

References (28)

1. Quezado, Z. M., Hoffman, W. D., Winkelstein, J. A., Yatsiv, I., Koev, C. A., Cork, L. C., Elin, R. J., Eichacker, P. Q., Natanson, C. (1994) The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure. J. Exp. Med. 179, 569-578.
2. Fischer, M. B., Prodeus, A. P., Nicholson-Weller, A., Ma, M., Murrow, J., Reid, R. R., Warren, H. B., Lage, A. L., Moore, F. D., Rosen, F. S., Carroll, M. C. (1997) Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J. Immunol. 159, 976-982.
3. May, J. E., Kane, M. A., Frank, M. M. (1972) Host defense against bacterial endotoxemia - contribution of the early and late components of complement to detoxification. J. Immunol. 109, 893-895.
4. Wessels, M. R., Butko, P., Ma, M., Warren, H. B., Lage, A. L., Carroll, M. C. (1995) Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92, 11490-11494.
5. Johnson, K. J., Ward, P. A. (1971) Protective function of C6 in rabbits treated with bacterial endotoxin. J. Immunol. 106, 1125-1127.
6. Barton, P. A., Warren, J. S. (1993) Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock. Infect. Immun. 61, 1474-1481.
7. Wang, Y., Hu, Q., Madri, J. A., Rollins, S. A., Chodera, A., Matis, L. A. (1996) Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc. Natl. Acad. Sci. USA 93, 8563-8568.
8. Wang, Y., Rollins, S. A., Madri, J. A., Matis, L. A. (1995) Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl. Acad. Sci. USA 92, 8955-8959.
9. Kroshus, T. J., Rollins, S. A., Dalmasso, A. P., Elliott, E. A., Matis, L. A., Squinto, S. P., Bolman, R. M., 3rd (1995) Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation. Transplant. 60, 1194-1202.
10. Ward, P. A., Zwaivler, N. J. (1973) Quantitative phagocytosis by neutrophils. II. Release of the C5-cleaving enzyme and inhibition of phagocytosis by rheumatoid factor. J. Immunol. 111, 1777-1782.
11. Hill, J. H., Ward, P. A. (1969) C3 leukotactic factors produced by a tissue protease. J. Exp. Med. 130, 505-518.
12. Ward, P. A., Chapitis, J., Conroy, M. C., Lepow, I. H. (1973) Generation by bacterial proteinases of leukotactic factors from human serum and C3 and C5. J. Immunol. 110, 1003-1009.
13. Foreman, K. E., Vaporciyan, A. A., Bonish, B. K., Jones, M. L., Johnson, K. J., Glovsky, M. M., Eddy, S. M., Ward, P. A. (1994) C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94, 1147-1155.
14. Morgan, B. P. (1989) Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem. J. 264, 1-14.
15. Podack, E. R. (1988) Cytolytic Lymphocytes and Complement. (E. R. Podack, ed.) Boca Raton, FL: CRC Press, 173-184.
16. Ramm, L. E., Whitlow, M. B., Mayer, M. M. (1985) The relationship between channel size and number of C9 molecules in the C5b-9 complex. J. Immunol. 134, 2594-2599.
17. Stewart, J. L., Monahan, J. B., Brickner, A., Sodetz, J. M. (1984) Measurement of the ratio of the eight and ninth components of human complement on complement-lysed membranes. Biochemistry 23, 4016-4022.
18. Langlois, P. F., Gawryl, M. S. (1988) Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138, 368-375.
19. Perkinson, D. T., Baker, P. J., Couser, W. G., Johnson, R. J., Adler, S. (1985) Membrane attack complex deposition in experimental glomerular injury. Am. J. Pathol 120, 121-128.
20. Mulligan, M. S., Schmid, E., Beck-Schimmer, B., Till, G. O., Friedl, H. P., Brauer, R. B., Hugli, T. E., Miyasaka, M., Warner, R. L., Johnson, K. J., Ward, P. A. (1996) Requirement and role of C5a in acute lung inflammatory injury in rats. J. Clin. Invest. 98, 503-512.
21. Schmid, E., Warner, R. L., Crouch, L. D., Friedl, H. P., Till, G. O., Hugli, T. E., Ward, P. A. (1997) Neutrophil chemotactic activity and C5a following systemic activation of complement in rats. Inflammation 21, 325-333.
22. Hattori, R., Hamilton, K. K., McEver, R. P., Sims, P. J. (1989) Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J. Biol. Chem. 264, 9053-9060.
23. Mulligan, M. S., Policy, M. J., Bayer, R. J., Nunn, M. F., Paulson, J. C., Ward, P. A. (1992) Neutrophil-dependent acute lung injury, requirement for P-selectin (GMP-140). J. Clin. Invest. 90, 1600-1607.
24. Mulligan, M. S., Schmid, E., Till, G. O., Hugli, T. E., Friedl, H. P., Roth, R. A., Ward, P. A. (1997) C5a-dependent upregulation in vivo of lung vascular P-selectin. J. Immunol. 158, 1857-1861.
25. Kilgore, K. S., Shen, J. P., Miller, B. F., Ward, P. A., Warren, J. S. (1995) Enhancement by the complement membrane attack complex of TNFα-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol. 155, 1434-1441.
26. Kilgore, K. S., Schmid, E., Shanley, T. P., Flory, C. M., Maheswari, V., Tramontini, N. L., Cohen, H., Ward, P. A., Friedl, H. P., Warren, J. S. (1997) Sublytic concentrations of the membrane attack complex (MAC) of complement induce endothelial interleukin 8 (IL-8) and monocyte protein 1 (MCP-1) through nuclear factor-κB activation. Am. J. Pathol. 150, 2019-2031.
27. Murphy, H. S., Shayman, J. A., Till, G. O., Maroughui, M., Owens, C. B., Ryan, U. S., Ward, P. A. (1992) Superoxide responses of endothelial cells to C5a and TNFα: divergent signal transduction pathways. Am. J. Physiol. 263, L51-L59.
28. Vaporciyan, A. A., Mulligan, M. S., Warren, J. S., Barton, P. A., Miyasaka, M., Ward, P. A. (1995) Up-regulation of lung vascular ICAM-1 in rats is complement dependent. J. Immunol. 155, 1442-1449.